SEARCH RESULTS FOR:

United States
Pharma & Life Sciences

Josh Grauso

SALES MANAGER, UL CONSUMER & RETAIL SERVICES
United States Biopharmaceuticals 2017
UL helps companies meet safety and compliance standards and regulations across the pharma industry.
United States
Pharma & Life Sciences

Quality: A Means for Value Creation

United States Biopharmaceuticals 2017
Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.
United States
Pharma & Life Sciences

Regulating Quality

United States Biopharmaceuticals 2017
Maintaining Safeguards Whilst Lowering Barriers to Market Entry.
Aerospace
Canada

Chris O’Neill

PRESIDENT & COO, MECAER AMERICA INC.
Québec Aerospace 2017
Mecaer America Inc. specializes in the design, manufacturing and qualification of integrated landing gear systems.
Mining
Chile

Sergio Hernández Núñez

EXECUTIVE VICE PRESIDENT, CHILEAN COPPER COMMISSION (COCHILCO)
Chile Mining 2018 Expomin Official Investment Guide
Cochilco provides the Chilean copper mining industry with vital strategic information with which to guide strategy.
Mining
South Africa
Ethiopia
MACIG

MACIG 2018 PRE-RELEASE

Aerospace
Canada

Jean-François Dupont

CEO, AV&R
Québec Aerospace 2017
AV&R is an engineering firm specializing in automation, vision and robotics with a history dating back to 1994.
Mining
Australia

Nigel Forrester

MANAGING DIRECTOR, MOUNT BURGESS
Western Australia Mining 2017 Pre-Release
Mount Burgess’ Kihabe project in Botswana is preparing a feasibility study this year as it aims at significant zinc production.
Mining
Chile

Pedro Damjanic

SENIOR VP OF MINING, FINNING CHILE
Chile Mining 2018 Expomin Official Investment Guide
Finning Chile explains how its Caterpillar equipment business adapted to current conditions and how it envisages the next.
Mining
Canada

James Hume

PRESIDENT, EAGLE MAPPING
British Columbia, Yukon and Vancouver Mining 2017
Eagle Mapping are busy Lidar scanning the northern parts of B.C. and Yukon from the air.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL